Involve primary-care doctor in retinal artery occlusion

Article

Referral to a primary-care physician is a critical component in the care of patients with a retinal artery occlusion because the ophthalmic event usually is a manifestation of a systemic disease, which by itself is associated with increased morbidity and mortality, according to experts.

Editor's Note: The February, March, and April issues of Optometry Times will explore why and how optometrists should look at patients globally in terms of their overall systemic health. Further emphasis will be placed on working collaboratively with colleagues in primary care and retina to ensure that all treatable conditions are addressed and to help patients maintain optimal vision.

In this three-part series, Advanstar Communications' Action for Outcomes initiative returns, this time with an in-depth look at vascular conditions. As well as serving as a wake-up call, the action plan emphasizes core competencies, best practices, and shared responsibility among all stakeholders in the patient's health-care ecosystem. An interdisciplinary approach to addressing this matter will provide specific knowledge and practical strategies to improve the treatment of patients with these conditions.

"The importance of determining and addressing the underlying cause of retinal arterial occlusive disease is underscored by available data that show post-event mortality rates of [about] 15% at 1 year and 55% after 7 years," said Dr. Gurwood, professor of clinical sciences, The Eye Institute of the Pennsylvania College of Optometry, Salus University, Philadelphia.

"Heyreh dispels the myth that an embolus does not have to be completely lodged in the vessel for occlusion to occur," he said. "It has to be stuck like a cork in a wine bottle. If the occlusion is not complete and blood can flow around the obstruction, patients will remain unaware of their precarious position."

Recent Videos
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
© 2024 MJH Life Sciences

All rights reserved.